Over 90% of patients with severely damaged corneas responded to the treatment in an early clinical trial.
Groundbreaking Stem Cell Therapy Repairs Badly Damaged Corneas and Improves Sight
Related Posts
Imperva has invested in strengthening our API Security offering to…